Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04887870
Title Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
Rocky Mountain Cancer Centers Aurora Colorado 90012 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Minnesota Health Clinics and Surgery Center Minneapolis Minnesota 55455 United States Details
GU Research Network/Urology Cancer Center Omaha Nebraska 68130 United States Details
New York Oncology Hematology, P.C. Clifton Park New York 12065 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
The Ohio State University Wexner Medical Center - Thoracic Oncology Clinic Columbus Ohio 43210 United States Details
Texas Oncology - Denison Cancer Center Denison Texas 75020 United States Details
UT MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field